@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix prov: . @prefix obo: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix hasPart: . @prefix ProteinComplex: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasPart: mgi:1277207, sub:_2; occursIn: obo:CL_0000236, species:10090; a ProteinComplex: . sub:_2 geneProductOf: mgi:1888984; a Protein: . sub:assertion rdfs:label "complex(p(MGI:Tbx21),g(MGI:Cxcr3))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "By utilizing a chromatin immunoprecipitation assay coupled to genomic microarray technology approach, we identified numerous promoters, including CXCR3, IL2Rbeta, and CCL3, that are bound by T-bet in B cells. (from text): The data in Fig. 2 show the validation of numerous promoter regions that are specifically bound by T-bet in B cells.... Most interestingly, all of the targets identified in the B cells are also bound by T-bet in the Jurkat T cells (Fig. 3B)."; prov:wasQuotedFrom pubmed:16473879 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:16473879; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:56.179+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }